Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shea

Showing results (241-250 of 248) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 248 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 5, 2016
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR OutcomesChristopher R Flowers, Luciano J Costa, Marcelo C Pasquini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell TransplantationRobert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Leukemia|May 11, 2019
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR studyCelalettin Ustun, Jennifer Le-Rademacher, Hai-Lin Wang, et al.
The New England Journal of Medicine|May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myelomaPhilip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2018
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR AnalysisWilliam A Wood, Ruta Brazauskas, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantationMehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Pageof 25

Showing results (241-250 of 248) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 248 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 5, 2016
Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR OutcomesChristopher R Flowers, Luciano J Costa, Marcelo C Pasquini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2017
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell TransplantationRobert J Soiffer, Haesook T Kim, Joseph McGuirk, et al.
Leukemia|May 11, 2019
Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR studyCelalettin Ustun, Jennifer Le-Rademacher, Hai-Lin Wang, et al.
The New England Journal of Medicine|May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myelomaPhilip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Cancer|June 18, 2016
Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisAbhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 24, 2018
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR AnalysisWilliam A Wood, Ruta Brazauskas, Zhen-Huan Hu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantationMehdi Hamadani, Parameswaran N Hari, Ying Zhang, et al.
Pageof 25